Prices are updated after-hours



nasdaq:CNVVF ConvaTec Group PLC/ADR

CNVVF | $3.685 -18.0% 6.4K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-3.0% 1m) (31.6% 1y) (0.0% 2d) (0.0% 3d) (-5.0% 7d) (2130.18% volume)
Earnings Calendar:
Market Cap: $ 7,553,474,525

http://www.convatec.com
Sec Filling | Patents | n/a employees


(GB) ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.

treatment   diabetic   diabetes  

add to watch list Paper trade email alert is off

nasdaq:ABCZF Abcam plc

ABCZF | $22.1 -2.32% 4K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (0.0% 1m) (70.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1011.11% volume)
Earnings Calendar:
Market Cap: $ 5,484,184,018

http://abcam.com
Sec Filling | Patents | n/a employees


(GB) Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.

antibody  

add to watch list Paper trade email alert is off

nasdaq:ANPCF ANGLE plc

ANPCF | $0.148 641.22% 5K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (0.0% 1m) (-11.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1011.11% volume)
Earnings Calendar:
Market Cap: $ 38,565,921

https://angleplc.com
Sec Filling | Patents | n/a employees


(GB) ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.

msa   ceiling   diagnostics   cancer   t-cell  

add to watch list Paper trade email alert is off

nasdaq:SLNCF Silence Therapeutics plc

SLNCF | $8.0 1.3K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-5.9% 1m) (506.0% 1y) (0.0% 2d) (0.0% 3d) (1.3% 7d) (478.7% volume)
Earnings Calendar:
Market Cap: $ 618,317,440

http://silence-therapeutics.com
Sec Filling | Patents | n/a employees


(GB) Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

t-cell   ceiling  

add to watch list Paper trade email alert is off

nasdaq:GLAXF GLAXOSMITHKLINE PLC

GLAXF | $20.2 510 twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-3.6% 1m) (3.4% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-50.0% volume)
Earnings Calendar:
Market Cap: $ 83,933,818,910

http://gsk.com
Sec Filling | Patents | n/a employees


(GB) GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

brands   hepatitis   infectious disease   respiratory   vaccine   battery   batteries   pain relief   gastrointestinal   skin   pets   influenza  

add to watch list Paper trade email alert is off

nasdaq:AZNCF ASTRAZENECA PLC

AZNCF | $135.94 770 twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (3.8% 1m) (-7.4% 1y) (0.0% 2d) (0.0% 3d) (-0.2% 7d) (-20.48% volume)
Earnings Calendar:
Market Cap: $ 213,093,418,272

http://astrazeneca.com
Sec Filling | Patents | n/a employees


(GB) AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

respiratory   urea   metabolic   cardiovascular  

add to watch list Paper trade email alert is off

nasdaq:SNNUF SMITH & NEPHEW PLC

SNNUF | $12.07 480 twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-6.1% 1m) (-24.8% 1y) (-1.6% 2d) (-1.6% 3d) (-1.6% 7d) (-32.68% volume)
Earnings Calendar:
Market Cap: $ 10,404,584,381

http://smith-nephew.com/
Sec Filling | Patents | n/a employees


(GB) Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.



add to watch list Paper trade email alert is off

Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
53% 47%

Top 10 Gainers
WISA 4 | $7.86 349.14% 120M twitter stocktwits trandingview |
Electronic Technology

TPET | $0.4951 114.24% 29M twitter stocktwits trandingview |
n/a

PRSO | $1.99 56.69% 52M twitter stocktwits trandingview |
Manufacturing

PALI | $6.5 56.25% 22M twitter stocktwits trandingview |
Manufacturing

JAGX | $0.1767 48.74% 430M twitter stocktwits trandingview |
Health Technology

SXTC | $2.03 45.0% 27M twitter stocktwits trandingview |
Health Technology

SPCB | $0.3888 40.87% 27M twitter stocktwits trandingview |
Electronic Technology

DYNT | $0.52 40.39% 20M twitter stocktwits trandingview |
Health Technology

SNGX | $0.54 39.86% 7.3M twitter stocktwits trandingview |
Health Technology

BSGM | $1.53 39.09% 2.6M twitter stocktwits trandingview |
Health Technology


Last 48 Hours Insiders Buying
RVP P 3587 | $1.06 -1.85% 21K twitter stocktwits trandingview |
Health Technology
| 17:00
TPL P 12 | $588.26 0.75% 12K twitter stocktwits trandingview |
Miscellaneous
| 16:01
HNRA | $2.617 10.89% 260K twitter stocktwits trandingview |
n/a
| 15:02
TGEN | $0.67 16K twitter stocktwits trandingview |
Utilities
| 14:30
RMCF | $3.6492 9.1K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar